Finance

Lists
Why is ALMR down 2.47%?
Dive Deeper
ALMR:NASDAQ
Alamar Biosciences Inc
$25.27
-2.47%
(-0.64) 1D
$25.06
-0.83% (-0.21)
After hours
Closed: Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMR...
Open
$25.97
High
$26.60
Low
$24.23
Mkt. cap
1.75B
Avg. vol.
529.42K
Volume
1.13M
52-wk high
$39.61
52-wk low
$18.84
Shares outstanding
69.39M
No. of employees
286
Open
$25.97
High
$26.60
Low
$24.23
Mkt. cap
1.75B
Avg. vol.
529.42K
Volume
1.13M
52-wk high
$39.61
52-wk low
$18.84
Shares outstanding
69.39M
No. of employees
286
News stories
From web sources and news partners
About Alamar Biosciences Inc
CEO-
Employees286
Founded2018
Headquarters-
SectorHealth care
Websitealamarbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ALMR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ALMR in the last 3 months.
Highest
Current $25.27
$35.00 (+38.50%)
Average
$33.00 (+30.59%)
Lowest
$31.00 (+22.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ryskin
Bank of America Securities
Hold
Reiterated
$31.00
+22.7%
08/10/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
$35.00
+38.5%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$32.00
+26.6%
08/11/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$34.00
+34.5%
07/15/2026
Puneet Souda
Leerink Partners
Buy
Initiated
$35.00
+38.5%
05/12/2026
Last report
Aug 10, 2026
Fiscal period
Q2 2026
-$0.20 / -$0.32
+37.43%beat
Revenue / Est. (USD)
29.43M / 25.94M
+13.45%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
13.09M
16.16M
26.04M
29.43M
Cost of goods sold
6.70M
7.58M
11.58M
11.71M
Cost of revenue
6.70M
7.58M
11.58M
11.71M
Research and development expenses
8.30M
8.90M
13.02M
13.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.64M
7.60M
13.79M
17.43M
Operating expense
14.94M
16.50M
26.80M
31.25M
Total operating expenses
21.64M
24.08M
38.38M
42.96M
Operating income
-8.55M
-7.92M
-12.35M
-13.53M
Other non operating income
-
-
-
-
EBT including unusual items
-7.66M
-7.02M
-20.86M
-13.29M
EBT excluding unusual items
-7.66M
-7.02M
-12.27M
-11.92M
Income tax expense
-
-
464.00K
-93.00K
Effective tax rate
-
-
-2.22%
0.70%
Other operating expenses
-
-
-
-
Net income
-7.66M
-7.02M
-21.32M
-13.20M
Net profit margin
-58.51%
-43.45%
-81.91%
-44.85%
Earnings per share
-
-
-
-0.20
Interest and investment income
786.00K
630.00K
539.00K
1.88M
Interest expense
-46.00K
-48.00K
-223.00K
-224.00K
Net interest expenses
740.00K
582.00K
316.00K
1.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.66M
-7.00M
-11.18M
-12.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps